share_log

Truist Securities Reiterates Buy on ANI Pharmaceuticals, Maintains $70 Price Target

Truist Securities Reiterates Buy on ANI Pharmaceuticals, Maintains $70 Price Target

Truist Securities重申買入ANI Pharmicals,維持70美元的目標價
Benzinga ·  2023/08/21 09:56

Truist Securities analyst Gregory Fraser reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $70 price target.

Truist Securities分析師格雷戈裏·弗雷澤重申ANI Pharmicals(納斯達克股票代碼:ANIP)的買入並維持70美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論